Evaluation of Cognitive Function in a Suicidal Crisis

Suicide Clinical Trial

— CocaCS  

Official title:

Evaluation of Cognitive Function in a Suicidal Crisis and Interest to Achieve a MoCA Test in Acute Situations

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03519802
• Other study ID #: 2015_84
• Secondary ID: 2016-A00881-50
• Status: Recruiting
• Start date: September 20, 2016
• Est. completion date: October 2022

Study information

• Verified date: September 2020
• Source: University Hospital, Lille
• Contact: Vincent JARDON, MD
• Email: vincent.jardon[@]chru-lille.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aftermath of suicide is devastating, being the cause of 800 000 deaths every year worldwide. In France, suicide still causes about 10 000 deaths per year and the number of suicide attempts (SA) is estimated between 170 000 and 200 000 per year (InVS).

It is often thought that a suicidal crisis is only related to depression, as it actually is a far more complex phenomenon. A suicidal crisis can occur on various grounds like psychiatric disorders but also contextual events or somatic diseases and it has been hypothesized that suicidal ideas or inclinations could have a common and independent cognitive origin

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 165
• Est. completion date: October 2022
• Est. primary completion date: October 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Normal or corrected vision

• Having understood the information not and having signed the form of consent

• Being hospitalized for suicidal ideas (Score with inclusion at the level of Beck > 3) or after a suicide attempt of less than one week.

Exclusion criteria:

• Pregnant woman and/or nursing

• Diagnosed irrational pathology

• Known proven intellectual deficiency

• Patient whose physical or mental status does not allow to pass the tests of the study

• Being under supervision or trusteeship or private of freedom or in emergency

Related Conditions & MeSH terms

• Suicide

Locations

Country	Name	City	State
France	CHRU,Hôpital Fontan	Lille

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of patients having a score in MoCA test strictly under 26		at inclusion
Secondary	Variation in MoCA test scores between before (V1) and after hospitalization (V2)		an average at 3 months after inclusion
Secondary	Variation in scores to the subtests between between before (V1) and after hospitalization (V2)		an average at 3 months after inclusion
Secondary	Rate of patients having lower subtests scores than the standards		an average at 3 months after inclusion